NEUROLASER

GOAL

Evaluation of the efficacy of low-level laser therapy in the prevention of chemotherapy-induced neuropathy in breast cancer patients

STUDY DESIGN

Placebo-controlled, randomized trial with breast cancer patients undergoing neurotoxic chemotherapy at the Jessa Hospital (NCT03391271) from December 2017 until present. 

Control group (n=30)	Laser group (n=30)
Chemotherapy	​Chemotherapy
Placebo laser (2x/week, during chemotherapy period)	LLLT (2x/week, during chemotherapy period)

STUDY RESULTS

Study is still active and no preliminary results available

PUBLICATIONS

 

PARTNERS